No longer in OpenAlex W4226027162 OpenAlex Authors 0 Author list not loaded yet. Cited by 21 stored of 0 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial 2024 Emerging Microbes & Infections article Medicine Viral Infections and Outbreaks Research Open access 4 citations Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases 2024 Nature Communications article Medicine Viral Infections and Outbreaks Research Open access 23 citations Immunogenicity of an Extended Dose Interval for the Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children in the Democratic Republic of the Congo 2024 Vaccines article Medicine Viral Infections and Outbreaks Research Open access 5 citations Delivery and Safety of a Two-Dose Preventive Ebola Virus Disease Vaccine in Pregnant and Non-Pregnant Participants during an Outbreak in the Democratic Republic of the Congo 2024 Vaccines article Medicine Viral Infections and Outbreaks Research Open access 6 citations Computational mining of B cell receptor repertoires reveals antigen-specific and convergent responses to Ebola vaccination 2024 Frontiers in Immunology article Medicine Viral Infections and Outbreaks Research Open access 5 citations Safety and Immunogenicity of an Accelerated Ebola Vaccination Schedule in People with and without Human Immunodeficiency Virus: A Randomized Clinical Trial 2024 Vaccines article Medicine Viral Infections and Outbreaks Research Open access 5 citations Helminth exposure and immune response to the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen 2024 PLoS neglected tropical diseases article Medicine Viral Infections and Outbreaks Research Open access 6 citations Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen: A phase 3, randomized, double-blind, placebo-controlled trial 2024 Human Vaccines & Immunotherapeutics article Medicine Viral Infections and Outbreaks Research Open access cited by 2 patents 8 citations Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study 2024 Vaccines article Medicine Viral Infections and Outbreaks Research Open access 7 citations Prediction of long-term humoral response induced by the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola 2023 npj Vaccines article Medicine Viral Infections and Outbreaks Research Open access 10 citations Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans 2023 Frontiers in Immunology article Medicine Viral Infections and Outbreaks Research Open access 17 citations Safety and Immunogenicity of the Heterologous 2-Dose Ad26.ZEBOV, MVA-BN-Filo Vaccine Regimen in Health Care Providers and Frontliners of the Democratic Republic of the Congo 2023 The Journal of Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access 9 citations The Effect of Previous Exposure to Malaria Infection and Clinical Malaria Episodes on the Immune Response to the Two-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen 2023 Vaccines article Medicine Viral Infections and Outbreaks Research Open access 4 citations Safety, Immunogenicity, and Regimen Selection of Ad26.RSV.preF–Based Vaccine Combinations: A Randomized, Double-blind, Placebo-Controlled, Phase 1/2a Study 2023 The Journal of Infectious Diseases article Medicine Respiratory viral infections research Open access 21 citations Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola 2022 npj Vaccines article Medicine Viral Infections and Outbreaks Research Open access 22 citations Sequential use of Ad26-based vaccine regimens in NHP to induce immunity against different disease targets 2022 npj Vaccines article Biochemistry, Genetics and Molecular Biology Virus-based gene therapy research Open access 11 citations First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study 2022 PLoS ONE article Medicine Viral Infections and Outbreaks Research Open access 34 citations Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels 2022 Vaccines article Medicine Viral Infections and Outbreaks Research Open access 25 citations Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial 2022 PLoS Medicine article Medicine Viral Infections and Outbreaks Research Open access 65 citations Assessments of different batches and dose levels of a two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen 2021 npj Vaccines article Medicine Viral Infections and Outbreaks Research Open access 10 citations 1–20 of 21 Page 1 / 2 Next → References 0